BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27608840)

  • 1. Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells.
    Wang Y; Wang H; Pan T; Li L; Li J; Yang H
    Oncotarget; 2016 Sep; 7(39):64360-64370. PubMed ID: 27608840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of TGIF attenuates the tumorigenicity of A549 cells in vitro and in vivo.
    Wang Y; Pan T; Wang H; Li L; Li J; Zhang C; Yang H
    Tumour Biol; 2016 Sep; 37(9):12725-12730. PubMed ID: 27448304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of TGIF is involved in lung carcinogenesis.
    Wang Y; Wang H; Gao H; Xu B; Zhai W; Li J; Zhang C
    Tumour Biol; 2015 Dec; 36(12):9223-31. PubMed ID: 26091794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
    Wu CY; Chan CH; Dubey NK; Wei HJ; Lu JH; Chang CC; Cheng HC; Ou KL; Deng WP
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of STIM1 is involved in lung tumorigenesis.
    Wang Y; Wang H; Li L; Li J; Pan T; Zhang D; Yang H
    Oncotarget; 2016 Dec; 7(52):86584-86593. PubMed ID: 27863410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
    Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
    Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
    Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIST1H3D: A promising therapeutic target for lung cancer.
    Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
    Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and regulatory role of ultraconserved long non-coding RNA uc.77 in lung cancer].
    Yu XW; Zhou JZ; Xu EW; Liu JY; Li MC; Wu JJ; Yang QY
    Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1102-1111. PubMed ID: 36319456
    [No Abstract]   [Full Text] [Related]  

  • 14. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
    Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.
    Castaño Z; Vergara-Irigaray N; Pajares MJ; Montuenga LM; Pio R
    Int J Cancer; 2008 Apr; 122(7):1512-20. PubMed ID: 17973258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
    Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
    PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7c inhibits NSCLC cell proliferation by targeting HOXA1.
    Zhan M; Qu Q; Wang G; Liu YZ; Tan SL; Lou XY; Yu J; Zhou HH
    Asian Pac J Cancer Prev; 2013; 14(1):387-92. PubMed ID: 23534758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
    Song SG; Yu HY; Ma YW; Zhang F; Xu XY
    Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.